Card Id
|
Type Of Strain
|
Strain Name
|
Internal Code
|
Gene Symbol
|
Gene Name
|
Disease
|
Stock Type
|
Submitter
|
Developer
|
imsr
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm1Kwk
|
tmCKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm2Kwk
|
tmNKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm
|
129/Sv.129S4(ICR)-Parp1tm1Hsmm/Hsmm
|
Parp1
|
Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute)
|
|
|
Transgenic.
|
B6-Tg(Fabp2-PLIN)
|
perilipin transgenic B6-Tg(Fabp2-PLIN)
|
PLIN
|
Perilipin(Human)
|
Metabolism Physiology
|
|
Unknown Unknown
|
Mikiko Endo(Department of MedicineII, Hokkaido University Graduate School of Medicin)
|
Released publicly
|
|
Transgenic.
|
B6-Tg(Pax7-YFP)
|
Pax7-YFP
|
-
|
Pax7
|
Anatomy Development Metabolism Neurobiology Physiology
|
|
Ono Yusuke
|
(UNITECH)
|
|
|
Targeted mutant.
|
B6.129(ICR)-Parp1tm1Hsmm/Hsmm
|
B6.129(ICR)-Parp1tm1Hsmm/Hsmm
|
Parp1
|
Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmacetical Co. Ltd., National Cancer Center Reasearch Institute)
|
|
|
Targeted mutant.
|
B6.129-Atp1a2tm2Kwk
|
BL6N
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6.129-Atp1a3tm1Kwk
|
B6;129-Atp1a3tm1Kwk
|
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
Anatomy Development Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6.129-Atp1a3tm2Kwk
|
B6;129-Atp1a3tm2Kwk
|
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
Anatomy Development Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6.129-Avpr1btm1
|
B6.129V1b-KO B6.129-Avpr1btm1
|
Avpr1b
|
arginine vasopressin receptor 1B
|
Neurobiology Physiology
|
|
Unknown Unknown
|
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Cckartm1
|
C57BL/6-Cckartm1
|
Cckar
|
Cholecystokinin A receptor
|
Metabolism Neurobiology Physiology cancer
|
|
Okamura Takeshi
|
Soich Takiguchi(National Kyushu Cancer Center)
|
|
|
Targeted mutant.
|
B6.129-Chrm1tm1
|
1NJ B6.129-Chrm1tm1
|
Chrm1
|
cholinergic receptor, muscarinic 1, CNS
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm, Sci., Univ.Tokyo)
|
|
|
Targeted mutant.
|
B6.129-Chrm2tm1
|
2NJ B6.129-Chrm2tm1
|
Chrm2
|
cholinergic receptor, muscarinic 2, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm3tm1
|
3NJ B6.129-Chrm3tm1
|
Chrm3
|
cholinergic receptor, muscarinic 3, cardia
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm4tm1
|
4NJ B6.129-Chrm4tm1
|
Chm4
|
cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch.Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm5tm1
|
5NJ B6.129-Chrm5tm1
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(東京大学薬学部)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Cthtm1
|
Cth-Knockout
|
Cth
|
cystathionase (cystathionine gamma-lyase)
|
Development Metabolism Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University)
|
|
|
Targeted mutant.
|
B6.129-Edg3tm1Jch
|
SIP3-Knockout
|
Edg3
|
endothelial differentiation, sphingolipid G-protein-coupled receptor,3
|
Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Kcnj8tm1Kusm
|
Kir6.1 deficient mouse B6.129-Kcnj8tm1Kusm
|
Kcnj8 (Synonym:Kir6.1)
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
Neurobiology Physiology
|
|
Unknown Unknown
|
Susumu Seino(Div Cell & Mol Med, Kobe Univ Grad Sch Med)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Neu3tm1Myg
|
C57BL/6-Neu3tm1Myg
|
Neu3
|
neuraminidase3
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Yamaguchi Kazunori
|
Taeko Miyagi(Miyagi Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Pkmtm1Ntan
|
PkmM1
|
Pkm
|
pyruvate kinase, muscle
|
Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Tanuma Nobuhiro
|
Nobuhiro Tanuma(Miyagi Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6.129-Ptger2tm1Sna
|
EP2KO
|
Ptger2
|
prostaglandin E receptor 2 (subtype EP2)
|
Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Narumiya Shuh
|
Shuh Narumiya(Kyoto University Graduate School of Medicine, Department of pharmacology)
|
|
|
Targeted mutant.
|
B6.129-S1pr2tm1Jch
|
SIP2-Knockout
|
S1pr2 (Synonym: Edg5)
|
Endothelial differentiation, sphingolipid G-protein-coupled receptor,5
|
Dermatology Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129P2-Olr1tm1Saw
|
B6-Lox-1 KO B6.129P2-Olr1tm1Saw
|
Orl1(Chr6, synonym:Lox-1)
|
lectin-like oxidized low density lipoprotein receptor-1
|
Metabolism Physiology
|
|
Unknown Unknown
|
National Cardiovascular Center(Tatsuya Sawamura)
|
|
|
Targeted mutant.
|
B6.129S7-Ttpatm1Csk
|
B6-α-Ttp KO B6.129S7-Ttpatm1Csk
|
Ttpa
|
tocopherol(alpha) transfer protein
|
Development Metabolism Neurobiology Physiology
|
|
Unknown Unknown
|
Jishage Kou-ichi(Chugai Pharmaceutical. co, Ltd.)
|
Released publicly
|
|
Targeted mutant.
|
B6.129Sv-Avpr1atm1
|
V1a knockout mouse B6.129Sv-Avpr1atm1
|
Avpr1a
|
arginine vasopressin receptor 1A
|
Physiology
|
|
Unknown Unknown
|
Tanoue Akito(National Center of Child Health and Development Research Institute Dept)
|
|
|
Transgenic.
|
B6.Cg-Tg(CAG-cre)CZ-MO2Osb
|
(CAG-cre)
|
Cre
|
Cre recombinase
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6.Cg-Tg(CAG-floxed Neo-EGFP)REP08Osb
|
REP-08
|
EGFP
|
green fluorescent protein
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6.D2-Tg(CAG-floxed Neo-DT)03Osb
|
REP-DT
|
DT
|
Diphtheria toxin gene subunit A
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6; FVB-Tg(VE-cadherin-tTA,TRE-DSCR-1s-IRES-lacZ) /195
|
B6-Dox conditional EC-specific DSCR-1Tg
|
RCAN1.4, lacZ
|
hDSCR-1s, beta galactosidase
|
Anatomy Development Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Laura Benjamin(Harvard Univ. Center for Vascular Biology)
|
|
|
Targeted mutant.
|
B6;129(ICR)-Parp1tm1Hsmm Tg(GPT-delta)/Hsmm
|
B6;129(ICR)-Parp1tm1Hsmm TgN(GPT-delta)/Hsmm
|
Parp1 Parp1
|
Poly (ADP-ribose) polymerase family, member 1 Poly (ADP-ribose) polymerase family, member 1
|
Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
Hiroshi Suzuki, Mitsuko Masutani(Chugai Pharmaceutical Co. Ltd., National Cancer Center Research Institute)
|
|
|
Targeted mutant.
|
B6;129-Adra1dtm1
|
B6 α1D-AR-KO
|
Adra1d
|
Adrenergic recetor, alpha 1d
|
Physiology
|
|
Unknown Unknown
|
Tanoue Akito
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm2tm1 Chrm4tm1
|
M1M2M4KO
|
Chrm1 Chrm2 Chrm4
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 2 cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1 Chrm5tm1
|
M1M3M5KO
|
Chrm1 Chrm3 Chrm5
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1
|
M1M3KO
|
Chrm1 Chrm3
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm4tm1
|
M2M4KO, C57BL/6J, 2x4
|
Chrm2 Chrm4
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm5tm1
|
2x5
|
Chrm2 Chrm5
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm4tm1
|
3x4
|
Chrm3 Chrm4
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm5tm1
|
3x5
|
Chrm3 Chrm5
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm4tm1 Chrm5tm1
|
M4M5KO, C57BL/6J, 4x5
|
Chrm4 Chrm5
|
cholinergic receptor, muscarinic 4 cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-DSCR-1tm1ApoEtm1
|
DSCR-1, ApoE double knockout mouse
|
Apoe RCAN1
|
apolipoprotein E regulator of calcineurin 1
|
Anatomy Metabolism Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Juda Folkman, Sandra Ryeom(Harvard Univ. Medical School)
|
|
|
Targeted mutant.
|
B6;129-DSCR-1tm1ApoEtm1
|
DSCR-1, ApoE double knockout mouse
|
Apoe RCAN1
|
apolipoprotein E regulator of calcineurin 1
|
Anatomy Metabolism Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Juda Folkman, Sandra Ryeom(Harvard Univ. Medical School)
|
|
|
Targeted mutant.
|
B6;129-DSCR-1tm1ApoEtm1
|
DSCR-1, ApoE double knockout mouse
|
Apoe RCAN1
|
apolipoprotein E regulator of calcineurin 1
|
Anatomy Metabolism Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo) Juda Folkman, Sandra Ryeom(Harvard Univ. Medical School)
|
|
|
Targeted mutant.
|
B6;129-Fez2tm1
|
Fez2 mouse B6;129-Fez2tm1
|
Fez2
|
fasciculation and elongation protein zeta 2 (zygin II)
|
Anatomy Development Neurobiology Physiology
|
|
Unknown Unknown
|
YASUHITO WATANABE(Osaka Bioscience Institute)
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Hpcatm1Toho
|
hippocalcin B6; 129-HPCAtm1toho
|
Hpca
|
hippocalcin
|
Neurobiology Physiology
|
|
Unknown Unknown
|
Tamotsu Masaki(Dept. of Physiology, Toho Univ. Sch. of Med.)
|
Released publicly
|
|
Targeted mutant.
|
B6;129-Hpcal1tm1Toho
|
hippocalcin-like1 (Nvp3) B6;129-Hpcal1tm1Toho
|
Hpcal1
|
hippocalcin-like 1
|
Neurobiology Physiology
|
|
Unknown Unknown
|
Tamotsu Masaki(Dept. of Physiology, Toho Univ. Sch. of Med.)
|
|
|
Targeted mutant.
|
B6;129-Hprttm1(dscr-1-lacZ)
|
DSCR-1s-lacZ
|
Hprt
|
hypoxanthine guanine phosphoribosyl transferase
|
Anatomy Development Physiology cancer
|
|
Minami Takashi
|
Takashi Minami(RCAST, The Univ. of Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Mal2tm1
|
MAL2
|
Mal2
|
mal, T cell differentiation protein 2
|
Anatomy Development Metabolism Physiology
|
|
- -
|
Akihiro Harada(IMCR,Gunma University)
|
|
|
Targeted mutant.
|
B6;129-Mapttm1(Cre)
|
tau-Cre
|
Mapt(synonym: Tau)
|
microtubule-associated protein tau
|
Anatomy Development Neurobiology Physiology
|
|
- -
|
Akihiro Harada(IMCR in Gunma University) Akihiro Harada(IMCR in Gunma University)
|
|
|
Targeted mutant.
|
B6;129-Msrtm1Csk Lox-1tm1Saw
|
B6-SR-Lox-1 WKO B6;129-Msrtm1Csk Lox-1tm1Saw
|
Macrophage scavenger receptor-1(Chr 8), Lox1 (Chr)
|
Msr, Lox1
|
Metabolism Physiology
|
|
Unknown Unknown
|
National Research Center for Protozoat Diseare Obihiro University of Agriculture and Veterinary Medicine(Hiroshi Suzuki)
|
|